Targeting the oncogenic SND1-MTDH interface through drugbank-based virtual screening: structural and electronic insights from molecular docking, molecular dynamics, and DFT analyses
Current Pharmaceutical Analysis · 2026-11 · 22 (9) · 850-863
DOI: 10.1016/j.cpan.2026.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pharmaceutical Analysis, 2026-11. Verfasst von Alaa H.M. Abdelrahman und 7 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- King Saud University
Zitieren
APA
Abdelrahman, A. H., Mohamed, D. E., Sidhom, P. A., Attia, M. A., Hemia, R. R., Han, Y., Ibrahim, M. A., & El-Tayeb, M. A. (2026). Targeting the oncogenic SND1-MTDH interface through drugbank-based virtual screening: structural and electronic insights from molecular docking, molecular dynamics, and DFT analyses. Current Pharmaceutical Analysis, 22(9), 850-863. https://doi.org/10.1016/j.cpan.2026.10.005
Vancouver
Abdelrahman AH, Mohamed DE, Sidhom PA, Attia MA, Hemia RR, Han Y, et al. Targeting the oncogenic SND1-MTDH interface through drugbank-based virtual screening: structural and electronic insights from molecular docking, molecular dynamics, and DFT analyses. Current Pharmaceutical Analysis. 2026;22(9):850-863. doi:10.1016/j.cpan.2026.10.005
BibTeX
@article{Abdelrahman2026,
author = {Abdelrahman, Alaa H.M. and Mohamed, Dina E.M. and Sidhom, Peter A. and Attia, Mohamed A.A. and Hemia, Randa R.A. and Han, Yanshuo and Ibrahim, Mahmoud A.A. and El-Tayeb, Mohamed A.},
title = {Targeting the oncogenic SND1-MTDH interface through drugbank-based virtual screening: structural and electronic insights from molecular docking, molecular dynamics, and DFT analyses},
journal = {Current Pharmaceutical Analysis},
year = {2026},
volume = {22},
number = {9},
pages = {850--863},
doi = {10.1016/j.cpan.2026.10.005}
}
EUVIMED